Insulin glargine and lixisenatide Subcutaneous and Retrovir (Zidovudine Syrup)
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Retrovir (Zidovudine Syrup) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: zidovudine
Brand name: Retrovir
Synonyms: Retrovir (oral/injection), Retrovir
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Retrovir Infusion
- Insulin glargine and lixisenatide Subcutaneous-Retrovir Intravenous
- Insulin glargine and lixisenatide Subcutaneous-Retrovir oral/injection
- Insulin glargine and lixisenatide Subcutaneous-Revatio
- Insulin glargine and lixisenatide Subcutaneous-Revatio Injection
- Insulin glargine and lixisenatide Subcutaneous-Revatio Intravenous
- Retrovir (Zidovudine Syrup)-Insulin glargine, recombinant Subcutaneous
- Retrovir (Zidovudine Syrup)-Insulin glulisine
- Retrovir (Zidovudine Syrup)-Insulin Glulisine (Cartridges and Pens)
- Retrovir (Zidovudine Syrup)-Insulin Glulisine (Vials)
- Retrovir (Zidovudine Syrup)-Insulin glulisine Subcutaneous
- Retrovir (Zidovudine Syrup)-Insulin human inhaled Inhalation